Literature DB >> 27417722

Gene expression of proteins of the vesicle cycle in dopaminergic neurons in modeling of Parkinson's disease.

E R Mingazov1, M V Ugrumov2.   

Abstract

It is assumed that one of the causes of the degeneration of dopaminergic neurons is the dysregulation of the vesicle cycle, which is ensured by a number of proteins including syntaxin I, synaptotagmin I, complexins I and II, and Rab5. It was shown that there is a compensatory increase in gene expression of proteins responsible for exocytosis at the preclinical stage of Parkinson's disease (PD) in the in substantia nigra (SN) in mice. Conversely, in the model of the clinical stage of PD, the decreases of gene expression of proteins responsible for exocytosis, endocytosis, and neuronal survival, which may be among the triggers of motor dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27417722     DOI: 10.1134/S1607672916030133

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  10 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.

Authors:  Elena A Kozina; Gulnara R Khakimova; Vitaly G Khaindrava; Valeriayn G Kucheryanu; Nadezhda E Vorobyeva; Alexey N Krasnov; Sophia G Georgieva; Lidiya Kerkerian-Le Goff; Michael V Ugrumov
Journal:  J Neurol Sci       Date:  2014-03-21       Impact factor: 3.181

Review 3.  Presynaptic function in health and disease.

Authors:  Clarissa L Waites; Craig C Garner
Journal:  Trends Neurosci       Date:  2011-05-17       Impact factor: 13.837

4.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Manuela Basso; Sabrina Giraudo; Davide Corpillo; Bruno Bergamasco; Leonardo Lopiano; Mauro Fasano
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

5.  Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.

Authors:  M V Ugrumov; V G Khaindrava; E A Kozina; V G Kucheryanu; E V Bocharov; G N Kryzhanovsky; V S Kudrin; V B Narkevich; P M Klodt; K S Rayevsky; T S Pronina
Journal:  Neuroscience       Date:  2011-03-05       Impact factor: 3.590

6.  Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra.

Authors:  Renee M Miller; Linda M Callahan; Cindy Casaceli; Linlin Chen; Gretchen L Kiser; Buena Chui; Tamma M Kaysser-Kranich; Timothy J Sendera; Chockalingam Palaniappan; Howard J Federoff
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

7.  Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

Authors:  Filip Simunovic; Ming Yi; Yulei Wang; Laurel Macey; Lauren T Brown; Anna M Krichevsky; Susan L Andersen; Robert M Stephens; Francine M Benes; Kai C Sonntag
Journal:  Brain       Date:  2008-12-03       Impact factor: 13.501

Review 8.  Rab GTPases and their roles in brain neurons and glia.

Authors:  Ee Ling Ng; Bor Luen Tang
Journal:  Brain Res Rev       Date:  2008-04-12

9.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15

Review 10.  The presynaptic active zone.

Authors:  Thomas C Südhof
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

  10 in total
  1 in total

Review 1.  Critical importance of RAB proteins for synaptic function.

Authors:  Maria Lidia Mignogna; Patrizia D'Adamo
Journal:  Small GTPases       Date:  2017-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.